SynCo signs two manufacturing agreements with US firm
This article was originally published in Scrip
Executive Summary
SynCo Bio Partners has signed two commercial manufacturing agreements with an unnamed US biopharmaceutical company to support the launch of two products in the US. It will provide process validation and commercial manufacturing services after taking part in the products' development.